Gender Male
LinkedIn View on LinkedIn
Antony has extensive experience of taking early stage start-ups to full commercial activity and has a career spanning both major multinationals (Johnson & Johnson, Fresenius and Howmedica (Stryker)) as well as a number of spin outs from the NHS (Tayflow Technologies) and universities (Tissue Regenix Group PLC). Most recently at Tissue Regenix
he took the company from a two-person spin- out to an AIM-listed company with operations in the UK, Germany and the US. Whilst CEO the company was listed on AIM and completed its first acquisition in the US of CellRight in August 2017. Current assignments include Director of NorthInvest (not for profit Angel network), Director of Tandem Nano Ltd and Executive Chair of EML. Antony owns two miniature dachshunds (Lottie & Lupin) and is a keen if inept gardener. He bakes great sourdough and enjoys cooking Italian and Middle Eastern food.
